- Tim Cook Should Tell Congress to Kiss His Ass
- Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
- 5 Worst Home Renovation Projects
- How the New York Hedge Funds Lost Their Shirts on Tesla
- What You Wear to the Office Still Matters
Apple: Keep Tim Cook's Feet to the Fire
Don't associate Tim Cook's performance on Capitol Hill with his ability to innovate at Apple.
Real Money Previews
Cramer: Recipe for Ringing the Register
The hottest stocks, in particular, could see some real mayhem ahead.
Kass: Are Valuations Peaking?
The market's P/E ratio appears to be stretched.
Cramer: They Were Wrong About Whole Foods
Thanks to health-conscious millennials, this company is in fine shape.
Mad Money Recap
'Mad Money' Lightning Round: I Like CVS Over Rite Aid
Cramer wants you to wait on Corning and AT&T and he's watching Oracle.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.
Stock Ideas
Apple: Keep Tim Cook's Feet to the Fire
Don't associate Tim Cook's performance on Capitol Hill with his ability to innovate at Apple.
'Mad Money' Lightning Round: I Like CVS Over Rite Aid
Cramer wants you to wait on Corning and AT&T and he's watching Oracle.
Cramer's Top Stock Picks: CLH SIX WFM
Investors can clean up with Clean Harbors, have fun with Six Flags and dine out on Whole Foods, Cramer said.
Can This OpenStack Be Saved?
Will big companies really build clouds incompatible with those they can rent?
Wendy's Transformation Is Progressing
Wendy's is not completely out of the woods just yet. But the company seems to be heading on the right path.
Personal Finance
Frequent Travelers Are the Ones Wasting Rewards Points
It's mainly men letting rewards points come and go, expiring even as they travel once a week or more.
Public Almost a Year, Healthcare Trust of America Is Still a Solid Buy
The health care REIT should do well when the federal health insurance law fully kicks in.
Apax Partners Retreads Rue21 Amid Retail Buyout Boom
Rue21 has agreed to its second buyout by private equity firm Apax Partners.
This Is How Much Women Love Smartphones and Not You
Most women in a survey would give up sex before their smartphone -- which they'll use to break up with you.
Starwood Upgraded as Capital Return Eyed
Hotelier seen sitting on $7 in excess capital that could be returned to shareholders.
Instant Spin
Stock Market Today
Stocks Fall on Signals of QE Tapering; Home Prices Rise
U.S. stocks stumble Thursday, even after better-than-expected labor and real estate reports.
Options Profits Previews
Developing a Relationship With Implied Volatility
CBOE's Russell Rhoads says there are two pieces of the puzzle that should help lead to the best option to buy or sell depending on your stock price forecast.
XLF Mega Bear Spreads
In the options market, hefty spreads on the XLF have been noteworthy and seem to be expressing concerns about a possible pullback in months ahead.
Trends in VIX Settlement
If you are unfamiliar with VIX derivatives, this is the week to watch the VIX options and futures move.
Biotech Stocks
Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE)
Two charts show how investors feel differently about Keryx and Acadia Pharma.
Rockwell Medical Run-Up Trade Follows Financing
One trader believes Rockwell shares will rise into clinical trial results expected in July.
2013 FDA Drug Approval Calendar
An updated list of the biotech and drug firms expecting FDA drug approval decisions in 2013.
Deal News
Apax Partners Retreads Rue21 Amid Retail Buyout Boom
Rue21 has agreed to its second buyout by private equity firm Apax Partners.
Bloomberg's 'Spygate' Marks Murdoch's Latest Salvo
The New York Post has played pitbull as News Corp. attempts to chip away at Bloomberg's profitable analytics business.
Tesla Is Just a Winning Stimulus as Fourth U.S. Automaker Emerges
Why taxpayers will only be able to view Tesla as a winning stimulus.
TheStreetTV
Spin Space
Jim Cramer
Cramer: Hewlett's Back
Jim Cramer believes Hewlett-Packard is back, but he's in wait and see mode before calling it an investment.
James Rogers
Investors Warm to HP but Big Challenges Remain
Investors may have been warming to HP ahead of its second-quarter results, but there are plenty of hurdles in CEO Meg Whitman's path.
Chris Ciaccia
HP Pops on Earnings Beat
HP's first-quarter earnings beat Wall Street expectations, sending the stock soaring in after-hours.
Laurie Kulikowski
Children's Place Spikes as Guidance Is Raised
Children's Place spikes Thursday after the children's apparel retailer lifts its fiscal-year guidance despite disappointing earnings results.
Philip van Doorn
Immelt Pushes Harder to Shrink GE Capital
General Electric CEO Jeff Immelt on Tuesday reiterated the firm's plan to keep shrinking its finance arm, hinting at possible spinoffs.
Dan Freed
Starwood Upgraded as Capital Return Eyed
Hotelier seen sitting on $7 in excess capital that could be returned to shareholders.
Adam Feuerstein
Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE)
Two charts show how investors feel differently about Keryx and Acadia Pharma.
Ted Reed
Chrysler to Tesla: Not So Fast on Payback Claim
Tesla says it's the only U.S. automaker to repay its federal loans, but Chrysler paid back its loans in 2011.
Rocco Pendola
Apple: Keep Tim Cook's Feet to the Fire
Don't associate Tim Cook's performance on Capitol Hill with his ability to innovate at Apple.
Anton Wahlman
Electric Cars: The Right and Wrong Reasons for Buying
When all is said and done, it's all about the actual driving experience.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
|
|
Brokerage Partners
|
|
|
|
|
|
|
|
Most Commented
Advertising Partners
|
|
Special Features